The Bachmann-Strauss Dystonia and Parkinson Foundation Company Profile

03:51 EST 15th December 2018 | BioPortfolio

The Bachmann-Strauss Dystonia & Parkinson Foundation was established in 1995 to find better treatments and cures for the movement disorders dystonia and Parkinson's disease and to provide medical and patient information. Lou Bachmann (1916-2000) and Bonnie Strauss founded The Bachmann-Strauss Dystonia & Parkinson Foundation (BSDPF) in 1995 as a nonprofit 501(c)3. The Foundation was started to encourage new scientific research in the fields of dystonia and Parkinson's disease and to heighten awareness about the diseases. The Foundation is also the leading organization actively looking at the interface between dystonia and Parkinson’s disease. Early stages of scientific research are often the hardest to fund. Following a similar concept to that of a "venture capital" fund, seed money is funded through annual grants, which help to leverage new ideas and advances in the fields. To date, the Foundation has raised over $35 million dollars and funded 235 grants in the U.S. and abroad.

News Articles [1001 Associated News Articles listed on BioPortfolio]

Idiopathic Adult-onset Laryngeal Dystonia

Researchers demonstrated that isolated laryngeal dystonia in an Italian population can spread to contiguous regions, thus expanding knowledge of dystonia spread and phenomenology of this rare form of ...

The Michael J Fox Foundation for Parkinson’s Research

In this interview, filmed at BioPharm in San Francisco, Dr Fintan Walton speaks with to Debi Brooks, Co-Founder of The Michael J Fox Foundation for Parkinson’s Research They discuss the foundation's...

New €10 million Parkinson's study

(University of Bristol) A new €10 million international trial to evaluate a new model of care that aims to improve the quality of life for people living with Parkinson's disease will be conducted wit...

Hilary Krane Joins the Gordon and Betty Moore Foundation Board of Trustees

The Gordon and Betty Moore Foundation today announced the election of a new trustee, Hilary Krane, executive vice president, chief administrative officer and general counsel for N...

High Rate of Waning Botox Efficacy in Dystonia, Spasticity

A 'surprisingly high' number of patients with dystonia or spasticity who receive botulinum neurotoxin type A develop neutralizing antibodies to the toxin over time, new research shows. Medscape Medi...

Milestone Moment: A Parkinson’s Drug Moves Forward With Help From Michael J.Fox

Today, at a medical conference being hosted by the Michael J. Fox Foundation, a biotechnology is presenting the first human data from a Parkinson’s drug that several of the world’s largest drug co...

Toward Adaptive Deep Brain Stimulation for Dystonia

Can neural oscillations serve as potential biomarkers that might be used as feedback signals for controlling adaptive deep brain stimulation in patients with dystonia? Neurosurgical Focus

04.23.12 -- Sanofi And Michael J. Fox Foundation Collaborate On Potential New Parkinson's Treatment

04/23/12 Bioresearch Online Newsletter

Drugs and Medications [824 Associated Drugs and Medications listed on BioPortfolio]

Esika [Ventura Corporation (San Juan, P.R)]

ēsika 3-in-1 Pro Make Up Foundation SPF 20

Sheer cover mineral foundation [Guthy-Renker LLC]

Sheer Cover Mineral Foundation SPF-15

Cle de peau beaute silky foundation i [SHISEIDO CO., LTD.]

CPB Silky Cream Foundation I

Cle de peau beaute foundation i [SHISEIDO CO., LTD.]

cle de peau BEAUTE Cream Foundation I

Shiseido perfect refining foundation [SHISEIDO AMERICA INC.]

SHISEIDO Perfect Refining Foundation

PubMed Articles [917 Associated PubMed Articles listed on BioPortfolio]

Toe dystonia in Parkinson's disease: Impact of subthalamic nucleus deep brain stimulation.

Off state toe dystonia (TD) is a symptom frequently encountered in Parkinson's disease (PD), but little is known about its evolution after subthalamic nucleus deep brain stimulation (STN-DBS).

Spread of dystonia in patients with idiopathic adult-onset laryngeal dystonia.

Adult onset laryngeal dystonia (LD) can be isolated or can be associated to dystonia in other body parts. Combined forms can be segmental at the onset or can result from dystonia spread to or from lar...

Bachmann's Bundle and interatrial conduction; comparing atrial morphology to electrical activity.

Bachmann's bundle (BB) is one of the major interatrial muscular connections. Macroscopic anatomy and electrophysiological properties of BB have so far not been linked and differences in activation pat...

Phenytoin induced dystonia.

Acar T, Alkan G, Çaksen H, Ertekin B, Ergin M, Koçak S, Cander B. Phenytoin induced dystonia. Turk J Pediatr 2018; 60: 111-112. The abnormalities of dopaminergic activity in the basal ganglia have b...

Dystonia as a network disorder: a concept in evolution.

This survey takes into consideration the most recent advances in both human degenerative ataxias, disorders with a well established cerebellar origin, and discoveries from dystonia rodent models aimed...

Clinical Trials [1600 Associated Clinical Trials listed on BioPortfolio]

Unlocking Dystonia From Parkinson's Disease With Directional DBS Technology

This study occurs during five visits that are already scheduled as part of "Biomarkers to Guide Directional DBS for Parkinson's Disease" ( Identifier: NCT03353688). If pa...

Osteopathic Manual Treatment Parkinson's Disease and Truncal Dystonia

In this study, we will determine if posture and heart rate variability will significantly improve in Parkinsons disease with camptocormia after osteopathic manual treatments dystonia.

DBS in the Treatment of Intractable Movement Disorders

The aim of this study is to observe the efficacy of Deep Brain Stimulation in the treatment of Parkinson's disease,Essential Tremors and Dystonia in our locality.

Humanitarian Device Exemption

The purpose of this study is to allow patients to undergo deep brain stimulation (DBS) surgery for the treatment of dystonia. This is NOT a research study, but rather, a requirement by th...

Mepolizumab As a Steroid-Sparing Treatment Option in the Churg Strauss Syndrome

The purpose of this study is to determine whether Mepolizumab (a monoclonal antibody against interleukin-5) is a safe and well-tolerated therapy that will allow for steroid tapering in pat...

Companies [1529 Associated Companies listed on BioPortfolio]

The Bachmann-Strauss Dystonia and Parkinson Foundation

The Bachmann-Strauss Dystonia & Parkinson Foundation was established in 1995 to find better treatments and cures for the movement disorders dystonia and Parkinson's disease and to...

Levi Strauss & Co.

Levi Strauss & Co. is one of the world’s largest branded apparel companies and the global leader in jeanswear, marketing its products in more than 110 countries worldwide. Th...

Dystonia Medical Research Foundation

The Michael J. Fox Foundation for Parkinson's Research

Founded in 2000, The Michael J. Fox Foundation for Parkinson's Research is dedicated to ensuring the development of a cure for Parkinson's disease through an aggressively funded research agenda. The F...

The Parkinson Alliance

The Parkinson Alliance is the umbrella organization for the Parkinson's Unity Walk. The Kingston, NJ-based national non-profit organization is dedicated to raising funds to help finance the most promi...

More Information about "The Bachmann-Strauss Dystonia and Parkinson Foundation" on BioPortfolio

We have published hundreds of The Bachmann-Strauss Dystonia and Parkinson Foundation news stories on BioPortfolio along with dozens of The Bachmann-Strauss Dystonia and Parkinson Foundation Clinical Trials and PubMed Articles about The Bachmann-Strauss Dystonia and Parkinson Foundation for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of The Bachmann-Strauss Dystonia and Parkinson Foundation Companies in our database. You can also find out about relevant The Bachmann-Strauss Dystonia and Parkinson Foundation Drugs and Medications on this site too.

Quick Search


Relevant Topics

Parkinson's Disease
Parkinson's is a progressive neurological condition, affecting one person in every 500, 95% of which are over 40. It is caused by degeneration of more than 70% of the substantia nigra, which depletes the dopamine (the neurotransmitter involved in pro...

Alzheimer's Disease
Of all the types of Dementia, Alzheimer's disease is the most common, affecting around 465,000 people in the UK. Neurons in the brain die, becuase  'plaques' and 'tangles' (mis-folded proteins) form in the brain. People with Al...

Corporate Database Quicklinks

Searches Linking to this Company Record